GALNT3-TTC21B Fusion FISH Probe
The GALNT3-TTC21B Fusion FISH Probe is used to confirm a fusion of the GALNT3 and TTC21B genes. The fusion of the GALNT3 and TTC21B genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| GALNT3-TTC21B-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| GALNT3-TTC21B-20-RERE | 20 (40 μL) | 200 μL |
|
|
| GALNT3-TTC21B-20-REOR | 20 (40 μL) | 200 μL |
|
|
| GALNT3-TTC21B-20-REGO | 20 (40 μL) | 200 μL |
|
|
| GALNT3-TTC21B-20-REGR | 20 (40 μL) | 200 μL |
|
|
| GALNT3-TTC21B-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| GALNT3-TTC21B-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| GALNT3-TTC21B-20-OROR | 20 (40 μL) | 200 μL |
|
|
| GALNT3-TTC21B-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| GALNT3-TTC21B-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| GALNT3-TTC21B-20-GORE | 20 (40 μL) | 200 μL |
|
|
| GALNT3-TTC21B-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| GALNT3-TTC21B-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| GALNT3-TTC21B-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| GALNT3-TTC21B-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| GALNT3-TTC21B-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| GALNT3-TTC21B-20-GROR | 20 (40 μL) | 200 μL |
|
|
| GALNT3-TTC21B-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| GALNT3-TTC21B-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| GALNT3-TTC21B-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| GALNT3-TTC21B-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| GALNT3-TTC21B-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| GALNT3-TTC21B-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| GALNT3-TTC21B-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| GALNT3-TTC21B-20-AQAQ | 20 (40 μL) | 200 μL |
|
GALNT3 Gene Summary
This gene encodes UDP-GalNAc transferase 3, a member of the GalNAc-transferases family. This family transfers an N-acetyl galactosamine to the hydroxyl group of a serine or threonine residue in the first step of O-linked oligosaccharide biosynthesis. Individual GalNAc-transferases have distinct activities and initiation of O-glycosylation is regulated by a repertoire of GalNAc-transferases. The protein encoded by this gene is highly homologous to other family members, however the enzymes have different substrate specificities. [provided by RefSeq, Jul 2008]
Gene Name: Polypeptide N-acetylgalactosaminyltransferase 3
Chromosome: CHR2: 166604312 -166650803
Locus: 2q24.3
TTC21B Gene Summary
This gene encodes a member of TTC21 family, containing several tetratricopeptide repeat (TPR) domains. This protein is localized to the cilium axoneme, and may play a role in retrograde intraflagellar transport in cilia. Mutations in this gene are associated with various ciliopathies, nephronophthisis 12, and asphyxiating thoracic dystrophy 4. [provided by RefSeq, Oct 2011]
Gene Name: Tetratricopeptide Repeat Domain 21B
Chromosome: CHR2: 166730452 -166810348
Locus: 2q24.3
Gene Diseases
The GALNT3 TTC21B Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Prostate Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|